|
CARA
|
Cara Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.04%
|
US
|
NASDAQ
|
|
WVE
|
WAVE Life Sciences Ltd.
|
0.04%
|
US
|
NASDAQ
|
|
KZR
|
Kezar Life Sciences, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
KOD
|
Kodiak Sciences Inc
|
0.04%
|
US
|
NASDAQ
|
|
INO
|
Inovio Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
|
TSVT
|
2seventy bio, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
SRRK
|
Scholar Rock Holding Corporation
|
0.03%
|
US
|
NASDAQ
|
|
SANA
|
Sana Biotechnology, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PSTX
|
Poseida Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PMVP
|
PMV Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PEPG
|
PepGen Inc.
|
0.03%
|
US
|
NASDAQ
|
|
NUVB
|
Nuvation Bio Inc.
|
0.03%
|
US
|
NYSE
|
|
NSTG
|
NanoString Technologies, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
MGNX
|
MacroGenics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
IMAB
|
I-Mab
|
0.03%
|
US
|
NASDAQ
|
|
IGMS
|
IGM Biosciences, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ERAS
|
Erasca, Inc
|
0.03%
|
US
|
NASDAQ
|
|
DSGN
|
Design Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
0.03%
|
US
|
NASDAQ
|